Search Within

Raymond P Warrell

Formats
  1. Journal Article (97)
  2. Meeting Abstract (68)
  3. Conference Paper (7)
  4. Book Section (3)
Groups
  1. Department of Medicine (56)
  2. Center for Hematologic Malignancies (42)
  3. Hematologic Malignancies, Division of (42)
  4. Adult Leukemia (33)
  5. Sloan Kettering Institute Faculty (25)
  6. Tow Center for Developmental Oncology (TCDO) (25)

More Groups

People
  1. Pier Pandolfi Derinaldis (28)
  2. Steven Soignet (25)
  3. David Scheinberg (24)
  4. Wilson Miller (20)
  5. Vincent Miller (19)
  6. William Tong (18)

More People

Years
  1. 2006 (2)
  2. 2004 (1)
  3. 2002 (1)
  4. 2001 (4)
  5. 2000 (11)
  6. 1999 (11)

More Years

Publications
  1. Blood (50)
  2. Journal of Clinical Oncology (12)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (12)
  4. Leukemia (11)
  5. Clinical Research (8)
  6. New England Journal of Medicine (8)

More Publications

Publishers
  1. American Society of Hematology (50)
  2. American Association for Cancer Research (22)
  3. American Society of Clinical Oncology (12)
  4. Nature Publishing Group (11)
  5. Massachusetts Medical Society (8)
  6. SLACK, Inc. (8)

More Publishers

Results (175)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Complete remission after clinically induced differentiation and apoptosis in acute promyelocytic leukemia by arsenic trioxide
    Meeting Abstract

    Soignet, S. L.; Maslak, P.; Chen, Y. W.; Calleja, E.; Pandolfi, P. P.; Scheinberg, D. A.; Warrell, R. P.
    British Journal of Haematology (1998)

    Fulltext@MSK | Save
  • Arsenic trioxide (As(2)O(3)) exerts its anti-leukemic effect by inhibiting angiogenesis
    Meeting Abstract

    Roboz, G. J.; Naiyer, A. J.; Warrell, R. P.; Rafii, S.
    Blood (1998)

    Fulltext@MSK | Save
  • Dose-ranging study of arsenic trioxide in advanced hematologic cancers: Clinical pharmacokinetic and biological effects
    Meeting Abstract

    Soignet, S.; Wang, Z. G.; Nagy, J.; Maslak, P.; Chanel, S.; Ho, R.; Spriggs, D.; Ellison, R.; Pandolfi, P. P.; Warrell, R. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Cell line AP-1060 with novel phenotypic and genotypic features established from acute promyelocytic leukemia (APL) patient clinically-resistant to all-trans retinoic-acid (RA) and arsenic trioxide (ATO)
    Meeting Abstract

    Kim, S. H.; Ding, W.; Cannizzaro, L.; Zohouri, M.; Gebhard, D.; Paietta, E.; Warrell, R. P.; Gallagher, R. E.
    Blood (1998)

    Fulltext@MSK | Save
  • Role of transcriptional repression and histone deacetylation in APL pathogenesis: A rationale for transcription therapy
    Meeting Abstract

    He, L. Z.; Guidez, F.; Warrell, R. P.; Zelent, A.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Arsenic trioxide in acute promyelocytic leukemia: Results of initial US pilot and multicenter trials
    Meeting Abstract

    Soignet, S.; Kantarjian, H.; Frankel, S.; Douer, D.; Tallman, M.; Scheinberg, D.; Pandolfi, P. P.; Ellison, R.; Warrell, R. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Transcription therapy for cancer: Effects of histone deacetylase (HDAC) inhibitors on proliferation, apoptosis and differentiation of leukemic cell lines
    Meeting Abstract

    He, L. Z.; Tolentino, T.; Warrell, R. P.; Zelent, A.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Therapeutic trials with arsenic trioxide (As(2)O(3)) and retinoic acid in PML-RAR alpha transgenic mice as models of APL
    Meeting Abstract

    Rego, E.; He, L. Z.; Wang, Z. G.; Peruzzi, D.; Warrell, R. P.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Targeted transcription therapy of acute promyelocytic leukemia using an inhibitor of histone deacetylase
    Meeting Abstract

    Warrell, R. P. Jr; He, L. Z.; Richon, V.; Calleja, E.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Western study of arsenic trioxide (As(2)O(3)) in patients with relapsed and/or refractory acute promyelocytic leukemia
    Meeting Abstract

    Soignet, S. L.; Maslak, P.; Chen, Y. W.; Calleja, E.; Pandolfi, P. P.; Scheinberg, D. A.; Warrell, R. P. Jr
    Annals of Oncology (1998)

    Fulltext@MSK | Save